Pharm- Chf/ Antiarrhythmics/ Antianginals

55 Questions | Total Attempts: 93

SettingsSettingsSettings
Please wait...
Pharm- Chf/ Antiarrhythmics/ Antianginals

Ready for more work on pharmacy? Today we’ll be looking at a number of different pharmaceuticals, including antiarrhythmic agents, which are used to suppress abnormal rhythms of the heart. What can you tell us about this and more?


Questions and Answers
  • 1. 
    CHF includes congestion of the pulmonary or systemic circulation (backward failure) and reduced output to body tissues (forward failure)
    • A. 

      True

    • B. 

      False

  • 2. 
    Which of the following  is not true about CHF
    • A. 

      May be a chronic or an acute condition

    • B. 

      Includes backwards and forward failure

    • C. 

      Kidneys retain sodium and water

    • D. 

      Leg and GI edema is seen in Left sided CHF

  • 3. 
    The triad of Right Ventricular Failure  features all of the following symptoms except
    • A. 

      JVD

    • B. 

      Clear Lungs

    • C. 

      Tachypnea

    • D. 

      Hypotension

  • 4. 
    Ascites, Pleural Effusion and Pericardial Effusion are Signs of Right Heart Failure
    • A. 

      True

    • B. 

      False

  • 5. 
    Which of the following would not be included in first line drug therapy for CHF?
    • A. 

      Fosiniopril (Monopril)

    • B. 

      Candesartan (Atacand)

    • C. 

      Metoprolol (Lopressor)

    • D. 

      Captopril (Capoten)

  • 6. 
    Which of the following is a second-line drug for CHF?
    • A. 

      Telmisartan (Micardis)

    • B. 

      Digoxin (Lanoxin)

    • C. 

      Inamrinone (Inocor)

    • D. 

      A&C

    • E. 

      B&C

  • 7. 
    ACE inhibitors/ARBs increase Cardiac Output in CHF and non CHF patients
    • A. 

      True

    • B. 

      False

  • 8. 
    Bumetanide (Bumex) and Fursimide (Lasix) are which class of drug
    • A. 

      Thiazide diuretics

    • B. 

      Loop Diuretics

    • C. 

      Phosphodiesterase inhibitors

    • D. 

      Cardiac Glycosides

  • 9. 
    Which of the following is a diuretics is less likely to be used in CHF because of its low level of effectiveness?
    • A. 

      Furosemide (Lasix)

    • B. 

      Metolazone (Zaroxolyn)

    • C. 

      Bumetanide (Bumex)

  • 10. 
    Which of the following is a Cardiac Glycoside?
    • A. 

      Furosemide (Lasix)

    • B. 

      Carvedilol (Coreg)

    • C. 

      Milrinone (Primacor)

    • D. 

      Digoxin (Lanoxin)

  • 11. 
    Which of the following is not true about Cardiac Glycosides?
    • A. 

      Positive Inotropic effects

    • B. 

      Negative chronotropic effects

    • C. 

      Indicated for VFib/Tachycardia

    • D. 

      Should be used cautiously in pregnancy

  • 12. 
    Which of the following drugs slows progression of heart failure and helps to reverse cardiac remodelling?
    • A. 

      Atenolol (Tenormin)

    • B. 

      Digoxin (lanoxin)

    • C. 

      Milrinone (Primacor)

    • D. 

      Hydralazine (Apresoline)

  • 13. 
    Which of the following is true about Phosphodiesterase inhibitors?
    • A. 

      Uusually used for long term therapy

    • B. 

      Includes Milrinone (Primacor) and Inamrinone (Inocor)

    • C. 

      Prevents ventricular dysrhythmias

    • D. 

      A & B

    • E. 

      B & C

  • 14. 
    Which of the following drugs reduce cardiac oxygen demand and are used when ACE inhibitors are not tolerated?
    • A. 

      Milrinone (Primacor)

    • B. 

      Nitroprusside (Nitropress)

    • C. 

      Digoxin (Lanoxin)

    • D. 

      Furosemide (Lasix)

  • 15. 
    Which of the following is true about Spironolactone?
    • A. 

      Is a direct aldosterone antagonist

    • B. 

      Prevents hyperkalemia and Na+ retention

    • C. 

      Reverses cardiac remodeling

    • D. 

      All of the above

  • 16. 
    Which of the following pacemaker-rate pairings are correct?
    • A. 

      SA node 40-60

    • B. 

      Ventricles 60-100

    • C. 

      AV Junction 40-60

    • D. 

      SA Node 20-40

  • 17. 
    Which of the following would not be an indication for Pharmacotherapy in Arrhythmia patients?
    • A. 

      Hemodynamic compromise occurs

    • B. 

      Decrease in myocardial oxygen demand

    • C. 

      Potential for malignant ventricular arrhythmias

    • D. 

      All of the above

  • 18. 
    Which of the following is inconsistent with the goals of antiarrhythmic therapy
    • A. 

      Restore and maintain normal sinus rhythm

    • B. 

      Suppress excitable areas outside normal pathway

    • C. 

      Control ventricular rate and optimize cardiac output

    • D. 

      None of the above

  • 19. 
    Which of the following is true about Class I Antiaarhythmic drugs??
    • A. 

      Divided into 3 sections

    • B. 

      Alters potassium concentration of cell membrane

    • C. 

      Alters sodium concentration of cell membrane

    • D. 

      A & C

    • E. 

      A & B

  • 20. 
    Which of the following Antiarrhythmic Classes is a Beta Blocker?
    • A. 

      I

    • B. 

      II

    • C. 

      III

    • D. 

      Ib

    • E. 

      IV

  • 21. 
    Class IV Antiarrhythmic drugs are _____________ blockers
    • A. 

      Beta

    • B. 

      Na+

    • C. 

      K+

    • D. 

      Ca++

    • E. 

      None of the above

  • 22. 
    Which of the following is a Class Ic Antiarrhythmic?
    • A. 

      Quinidine

    • B. 

      Propafenone (Rythmol)

    • C. 

      Lidocaine

    • D. 

      Mexiletene

  • 23. 
    Which of the following is a Class Ia Antiarrhythmic?
    • A. 

      Flecainide (Tambocor)

    • B. 

      Disopyramide (Norpace)

    • C. 

      Mexiletene

    • D. 

      A & B

  • 24. 
    Lidocaine and Mexiletene are which class of Antiarrhythmic?
    • A. 

      IV

    • B. 

      Misc

    • C. 

      Ib

    • D. 

      Ic

  • 25. 
    Which of the following drugs is a moderate sodium channel blocker and may promote Torsades des Pointes?
    • A. 

      Lidocaine

    • B. 

      Flecainide (Tambocor)

    • C. 

      Propafenone (Rythmol)

    • D. 

      Quinidine

Back to Top Back to top